@article {Yoshioka2021.02.27.21252458, author = {Takashi Yoshioka and Ryo Okubo and Takahiro Tabuchi and Satomi Odani and Tomohiro Shinozaki and Yusuke Tsugawa}, title = {Factors Associated with Serious Psychological Distress during the COVID-19 Pandemic in Japan}, elocation-id = {2021.02.27.21252458}, year = {2021}, doi = {10.1101/2021.02.27.21252458}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Importance The coronavirus disease 2019 (COVID-19) pandemic may have a negative impact on mental health of the population, leading to higher suicide rates, in many countries. However, little is known about risk factors associated with worsened mental health during the COVID-19 pandemic.Objective To investigate the factors associated with serious psychological distress (SPD) during the COVID-19 pandemic in Japan.Design, Setting, and Participants A cross-sectional study using a large-scale internet survey conducted between August 25 and September 30, 2020, in Japan.Exposures Demographics (age, gender, marital status, family composition, and caregiving burden), socio-economic status (income level, employment type, educational attainment), the experience of domestic violence (DV), the state of emergency, fear of COVID-19, and stigma related to COVID-19.Main Outcomes and Measures Prevalence of SPD, defined as Kessler 6 scale score >=13.Results Among 25,482 individuals included in this study, 2,556 (10\%) met the criteria of SPD. Overall, women (adjusted odds ratio [aOR] 1.59; 95\%CI, 1.17{\textendash}2.16; P=0.003), ages 15{\textendash}29 (aOR compared with ages 45{\textendash}59, 2.35; 95\%CI, 1.64{\textendash}3.38; P\<0.001), low income (aOR compared with intermediate income, 1.70; 95\%CI, 1.16{\textendash}2.49; P=0.007), providing caregiving to family members (aOR, 5.48; 95\%CI, 3.51{\textendash}8.56; P\<0.001), experiencing DV (aOR, 5.72; 95\%CI, 3.81{\textendash}8.59; P\<0.001), and fear of COVID-19 (aOR, 1.96; 95\%CI, 1.55{\textendash}2.48; P\<0.001) were associated with a higher rate of SPD. Among women aged 15{\textendash}29 years, who experienced the highest rate of SPD, caregiving, DV, fear of COVID-19, and COVID-19-related stigma were associated with a higher rate of SPD; whereas economic situation (income level and employment type) and social isolation (marital status) were not associated with the prevalence of SPD.Conclusions and Relevance Economic situation, caregiving burden, DV, and fear of COVID-19 were independently associated with SPD during the COVID-19 pandemic. Among young women{\textemdash}who have a higher risk of suicide during the COVID-19 pandemic in Japan{\textemdash}similar factors, except economic situation, were associated with a higher rate of SPD. Targeted interventions based on age and gender may be more effective in mitigating the negative impact of the COVID-19 pandemic on the population{\textquoteright}s mental health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding/Support: This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grants [grant number 17H03589;19K10671;19K10446;18H03107; 18H03062; 19H03860], the JSPS Grant-in-Aid for Young Scientists [grant number 19K19439], Research Support Program to Apply the Wisdom of the University to tackle COVID-19 Related Emergency Problems, University of Tsukuba, and Health Labour Sciences Research Grant [grant number 19FA1005;19FG2001; 19FA1012] and the Japan Agency for Medical Research and Development (AMED; grant number 2033648). Dr. Tsugawa was supported by the National Institutes of Health (NIH)/NIMHD Grant R01MD013913 and NIH/NIA Grant R01AG068633 for other work not related to this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. Role of the Funder/Sponsor: The funder had no role in design, conduct of this study; data collection, management, analysis, and interpretation; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Osaka International Cancer Institute approved this study (No. 20084).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study are not available in a public repository because they contain personally identifiable or potentially sensitive participants{\textquoteright} information. Based on the regulations for ethical guidelines in Japan, the Research Ethics Committee of the Osaka International Cancer Institute has imposed restrictions on the dissemination of the data collected in this study.}, URL = {https://www.medrxiv.org/content/early/2021/03/01/2021.02.27.21252458}, eprint = {https://www.medrxiv.org/content/early/2021/03/01/2021.02.27.21252458.full.pdf}, journal = {medRxiv} }